Looking ahead, Prosub remains dedicated to fostering partnerships, sharing knowledge, and driving innovation in the dye sublimation industry. With a focus on sustainable growth, Prosub is ...

Omitting SLNB in older patients with early-stage, HR-positive, HER2-negative breast cancer showed similar safety and efficacy to performing the procedure. The BOOG 13-08 trial demonstrated comparable ...

Please provide your email address to receive an email when new articles are posted on . Skipping sentinel lymph node biopsy can be considered for node-negative, HR-positive, HER2-negative early breast ...

To investigate this further, first author, Gabriella N. Tortorello, MD, and a research team from the University of Pennsylvania, performed a retrospective cohort study with data from the National ...

Omitting sentinel lymph node biopsy (SLNB) in patients with early-stage breast cancer undergoing breast-conserving surgery may not increase the risk for recurrence over 5 years, according to findings ...

Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...

Please provide your email address to receive an email when new articles are posted on . Armando E. Giuliano, MD, will receive the 2025 William L. McGuire Memorial Lecture Award. Giuliano is being ...

Meta Platforms Inc. has poached Apple Inc.’s most prominent design executive in a major coup that underscores a push by the social networking giant into AI-equipped consumer devices. The company is ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Miami-based real estate ...

Plantro Ltd., the investment firm controlled by former Dye & Durham Ltd. executive Matt Proud, has submitted a fresh proposal to take the legal software company private for about C$384 million ($273 ...